FFL
BIIB icon

Financial Freedom LLC’s Biogen BIIB Stock Holding History

Financial Freedom LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50
Closed -$9.17K – 133
2026
Q1 		$9.17K Hold
50
– – ﹤0.01% 310
2025
Q4 		$8.8K Hold
50
– – ﹤0.01% 276
2025
Q3 		$7K Hold
50
– – ﹤0.01% 290
2025
Q2 		$6.28K Hold
50
– – ﹤0.01% 298
2025
Q1 		$6.84K Hold
50
– – ﹤0.01% 301
2024
Q4 		$7.65K Hold
50
– – ﹤0.01% 293
2024
Q3 		$9.69K Hold
50
– – 0.01% 275
2024
Q2 		$11.6K Hold
50
– – 0.01% 263
2024
Q1 		$10.8K Hold
50
– – 0.01% 266
2023
Q4 		$12.9K Buy
+50
New +$12.3K 0.01% 252

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Financial Freedom LLC's BIIB Position: Q2 2026 in Review

Financial Freedom LLC sold out of Biogen (BIIB) in Q2 2026, closing a stake of 50 shares — an estimated $9.17K sold.

Financial Freedom LLC first reported a position in BIIB in Q4 2023 and held it in 10 quarters. The position peaked at $12.9K in Q4 2023. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Financial Freedom LLC reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Financial Freedom LLC sold 50 Biogen shares in Q2 2026, an estimated $9.17K.
  • Financial Freedom LLC first reported a position in Biogen in Q4 2023 and held it in 10 quarters.
  • Financial Freedom LLC's Biogen position peaked at $12.9K in Q4 2023.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Financial Freedom LLC's 13F filing for Q2 2026, filed 6 Aug 2026.